Literature DB >> 27684199

The Penetrated Delivery of Drug and Energy to Tumors by Lipo-Graphene Nanosponges for Photolytic Therapy.

Yu-Lin Su1, Kuan-Ting Chen1, Yu-Chen Sheu1, Shuo-Yuan Sung1, Ru-Siou Hsu1, Chi-Shiun Chiang1, Shang-Hsiu Hu1.   

Abstract

Delivery of drug and energy within responsive carriers that effectively target and accumulate in cancer cells promises to mitigate side effects and to enhance the uniquely therapeutic efficacy demanded for personalized medicine. To achieve this goal, however, these carriers, which are usually piled up at the periphery of tumors near the blood vessel, must simultaneously overcome the challenges associated with low tumor penetration and the transport of sufficient cargos to deep tumors to eradicate whole cancer cells. Here, we report a sponge-like carbon material on graphene nanosheet (graphene nanosponge)-supported lipid bilayers (lipo-GNS) that doubles as a photothermal agent and a high cargo payload platform and releases a burst of drug/energy (docetaxel (DTX) and gasified perfluorohexane (PFH)) and intense heat upon near-infrared irradiation. Ultrasmall lipo-GNS (40 nm) modified with a tumor-targeting protein that penetrates tumor spheroids through transcytosis exhibited a 200-fold increase in accumulation relative to a 270 nm variant of the lipo-GNS. Furthermore, a combination of therapeutic agents (DTX and PFH) delivered by lipo-GNS into tumors was gasified and released into tumor spheroids and successfully ruptured and suppressed xenograft tumors in 16 days without distal harm when subjected to a single 10 min near-infrared laser treatment. Moreover, no tumor recurrence was observed over 60 days post-treatment. This sophisticated lipo-GNS is an excellent delivery platform for penetrated, photoresponsive, and combined gasification/chemo-thermotherapy to facilitate tumor treatment and for use in other biological applications.

Entities:  

Keywords:  3D tumor model; drug delivery; graphene oxide; mesoporous structure; photoresponsive

Year:  2016        PMID: 27684199     DOI: 10.1021/acsnano.6b04414

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  8 in total

1.  High Directional Water Transport Graphene Oxide Biphilic Stack.

Authors:  Mohammad Moulod; Saeed Moghaddam
Journal:  Mol Simul       Date:  2022-02-28       Impact factor: 2.346

Review 2.  Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue.

Authors:  Muhammad Usman Munir
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 3.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.

Authors:  Yijing Liu; Pravin Bhattarai; Zhifei Dai; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2019-04-01       Impact factor: 54.564

4.  Polymer-Based Nanocarriers for Co-Delivery and Combination of Diverse Therapies against Cancers.

Authors:  Guowen Yan; Aihua Li; Aitang Zhang; Yong Sun; Jingquan Liu
Journal:  Nanomaterials (Basel)       Date:  2018-02-03       Impact factor: 5.076

Review 5.  Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration.

Authors:  Zimu Li; Xiaoting Shan; Zhidong Chen; Nansha Gao; Wenfeng Zeng; Xiaowei Zeng; Lin Mei
Journal:  Adv Sci (Weinh)       Date:  2020-11-27       Impact factor: 16.806

6.  Dual-drug nanomedicine with hydrophilic F127-modified magnetic nanocarriers assembled in amphiphilic gelatin for enhanced penetration and drug delivery in deep tumor tissue.

Authors:  Yen-Ho Lai; Chih-Sheng Chiang; Tzu-Hsun Kao; San-Yuan Chen
Journal:  Int J Nanomedicine       Date:  2018-05-22

7.  Graphene oxide suppresses the growth and malignancy of glioblastoma stem cell-like spheroids via epigenetic mechanisms.

Authors:  Xu Wang; Wenjuan Zhou; Xian Li; Jun Ren; Guangyu Ji; Jingyi Du; Wenyu Tian; Qian Liu; Aijun Hao
Journal:  J Transl Med       Date:  2020-05-14       Impact factor: 5.531

Review 8.  Functional Nanoparticles for Tumor Penetration of Therapeutics.

Authors:  Yu-Lin Su; Shang-Hsiu Hu
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.